CompletedNot Applicable

Description of Changes in NIRS as a Function of Ductus Arteriosus Status in Very Premature Babies Born Before 32 WG at the DIJON University Hospital

France26 participantsStarted 2023-10-16

Plain-language summary

Monitoring patent ductus arteriosus is currently performed using echocardiography, an operator-dependent examination which requires holding the child on their back and which is potentially time-consuming. This test is usually carried out on days 2, 4 and 7 after birth. NIRS (near-infrared spectroscopy) is a non-invasive method of monitoring tissue oxygen saturation using infrared light. The aim of the study was to investigate an association between cerebral and renal NIRS data and ductus arteriosus status obtained by echocardiography.

Who can participate

Age range48 Hours

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Parent who has agreed to participate in the study * Very premature newborn (born before 32 weeks' gestation) * Hospitalised in the Neonatal Intensive Care Unit at Dijon University Hospital * Before 48 hours of life Exclusion Criteria: * Newborn with congenital heart disease * Newborn with a congenital renal anomaly * Newborn with polymalformative syndrome * Newborn with a skin anomaly * Newborn with severe circulatory failure unrelated to the ductus arteriosus

What they're measuring

The ultrasound status of the ductus arteriosus

Timeframe: On day 2, day 4 and day 7 of life

Trial details

NCT IDNCT06153771

SponsorCentre Hospitalier Universitaire Dijon

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-14

View on ClinicalTrials.gov More Extremely Premature Newborn (Born Before 32 Weeks' Gestation) trials